Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02055105 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Modulation of Molecular Fingerprinting in Pediatric Sepsis

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Phase: Not applicable to Not specifiedv3 Show 5 more changesShow less
    • Enrollment target: 25 to 50
    • Primary completion date: Jun 2015 to Jun 2027
    • Study sites: 1 to 2
    • Study completion date: Aug 2015 to Oct 2027
    • Study arms: 1 to 2
  2. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date changed from estimate of Mar 2015 to Jun 2015
    • Study completion date: Jul 2015 to Aug 2015
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to demonstrate the sensitivity and specificity of detecting circulating micro RNA (miRNA) biomarkers in pediatric septic patients. It will also follow expression and modulation of levels in response to therapy in comparison to current biomarkers.
Trial Details
NCT Number NCT02055105
Lead Sponsor Phoenix Children's Hospital
Conditions
(from sponsor)		 Systemic Inflammatory Response Syndrome
Related terms Systemic Inflammatory Response Syndrome
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov